97933969 - PDPS

Information

  • Trademark
  • 97933969
  • Serial Number
    97933969
  • Filing Date
    May 12, 2023
    a year ago
  • Transaction Date
    May 08, 2024
    a month ago
  • Status Date
    February 07, 2024
    4 months ago
  • Location Date
    February 07, 2024
    4 months ago
  • Status Code
    641
  • Current Location
    TMEG LAW OFFICE 108 - EXAMINING ATTORNEY ASSIGNED
    Employee Name
    DAWE III, WILLIAM H
  • Attorney Docket Number
    PPDM 13733
    Attorney Name
    Harris A. Wolin
    Law Office Assigned Location Code
    L80
  • Owners
Mark Drawing Code
4
Mark Identification
PDPS
Case File Statements
  • GS0401: Manufacturing of synthetic peptides for others; Peptide synthesis for others; Manufacturing of pharmaceuticals and chemicals for others; Manufacturing of synthetic proteins for others; Amino acid synthesis for others
  • GS0051: Synthetic peptides for pharmaceutical use; Chemical preparations for pharmaceutical purposes; Pharmaceutical protein; Central nervous system drugs; Peripheral nerve drugs; Drugs affecting sensory organs; Antiallergic drugs; Cardiovascular drugs; Drugs affecting respiratory organs; Drugs affecting digestive organs; Drugs for outer skin; Blood solvent; Metabolic drugs; Cellular function activating drugs; Drugs for tumor treatment; Diagnostic drugs; Other drugs
  • GS0011: Chemical products; Chemicals for the manufacture of pharmaceuticals; Peptide; Analytical samples for research; Reagents for biological and chemical purposes and for research purposes, excluding those for medical or veterinary use; Proteins and peptides used in the research, development and manufacture of pharmaceuticals and biologicals; Chemical reagents used for the detection, measurement and identification of genetic materials or compounds, excluding those for medical and veterinary use
  • GS0421: Testing, examination or research related to pharmaceuticals, cosmetics, or foods, and the provision of information or advice thereto; Testing, examination, or research related to organisms or bacteria, and the provision of information or advice thereto; Testing, examination, or research related to chemistry, and the provision of information or advice thereto; Testing, examination, or research related to medical care, and the provision of information or advice thereto; Testing, examination, or research related to biotechnology, and the provision of information or advice thereto; Testing, examination, or research related to the identification of hit lead peptides, and the provision of information or advice thereto; Testing, inspection, or research related to the identification of hit-lead compounds, and the provision of information or advice thereto; Testing, inspection, or research related to the analysis and synthesis of peptides, and the provision of information or advice thereto Testing, inspection, or research related to the analysis and synthesis of proteins, and the provision of information or advice thereto; The generation of a library of peptides and the provision of information or advice thereto; Testing, examination, or research using automated screening machines and the provision of information or advice thereto; Clinical Trials; Quality control; Advice on quality control
Case File Event Statements
  • 5/16/2023 - a year ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 6/12/2023 - a year ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 2/6/2024 - 4 months ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 2/7/2024 - 4 months ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 2/7/2024 - 4 months ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 2/7/2024 - 4 months ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 5/7/2024 - a month ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA